Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

Eitemau Tebyg

• Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
  gan: Ezgi Ozyerli-Goknar, et al.
  Cyhoeddwyd: (2023-11-01)
• EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
  gan: Yedier-Bayram, O, et al.
  Cyhoeddwyd: (2022)
• The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
  gan: Ozyerli-Goknar, E, et al.
  Cyhoeddwyd: (2019)
• Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
  gan: Saraç, H, et al.
  Cyhoeddwyd: (2019)
• Homeotic shift at the dawn of the turtle evolution
  gan: Tomasz Szczygielski
  Cyhoeddwyd: (2017-01-01)